Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s site/release revision indicator was updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than any modification to the study details.SummaryDifference0.0%

- Check16 days agoChange DetectedA new revision v3.5.2 has been added, replacing the previous revision v3.5.0.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a publication citation for Olutasidenib in IDH1-mutated chondrosarcoma (Nat Commun 2026, 17(1):2224). Removed the Online ahead of print version.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded Hepatocellular carcinoma as a related topic and updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 in the page footer.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.2 has been added in place of Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.